MedPath

Menstrual Cycle Phase and Oral Contraceptive Pill (OCP) Use on Muscle Protein Synthesis

Not Applicable
Completed
Conditions
Menstrual Cycle
Resistance Exercise
Muscle Protein Synthesis
OCP
Interventions
Other: Unilateral Resistance Exercise Leg
Other: Control Leg
Registration Number
NCT05347667
Lead Sponsor
McMaster University
Brief Summary

Skeletal muscle size and function is regulated by various factors, including hormones. While we understand the role of male sex hormones (testosterone), we aren't sure how female sex hormones (estrogen and progesterone) influence muscle mass and strength. Female physiology is unique in that hormones fluctuate throughout the menstrual cycle. In the first phase (follicular phase) following menstruation, estrogen levels are high while progesterone levels are low. In the second phase (luteal phase), progesterone levels are high. Females are often excluded from studies because researchers are concerned that the menstrual cycle might affect the results. The purpose of this study is to investigate the response to resistance exercise in each phase of the menstrual cycle.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Healthy females, between the ages of 18 and 30 y with a regular menstrual cycle
  • Body Mass Index between 18.5 and 30.0 kg/m2
  • Able and willing to provide informed consent
Exclusion Criteria
  • A history of neuromuscular disorders or muscle/bone wasting diseases
  • Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin-dependent or insulin-independent diabetes, or the presence of any other metabolic disease - all of which will be determined via a medical history screening questionnaire
  • The use of any medications known to affect protein metabolism (glucocorticoids, non-steroidal anti-inflammatory medication, or prescription strength acne medication, etc.)
  • A (family) history of thrombosis
  • The use of anticoagulant medications
  • Consumption of tobacco-containing products
  • Excessive alcohol consumption (>21 units/wk)
  • History of bleeding diathesis, platelet or coagulation disorders
  • Currently pregnant
  • Irregular menstrual cycle as defined in the study protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pre-Ovulation Unilateral Resistance ExerciseControl LegOne leg will undergo 2 sessions of unilateral resistance exercise during the follicular phase of the menstrual cycle (pre-ovulation).
Pre-Ovulation Unilateral Resistance ExerciseUnilateral Resistance Exercise LegOne leg will undergo 2 sessions of unilateral resistance exercise during the follicular phase of the menstrual cycle (pre-ovulation).
Post-Ovulation Unilateral Resistance ExerciseUnilateral Resistance Exercise LegOne leg will undergo 2 sessions of unilateral resistance exercise during the luteal phase of the menstrual cycle (post-ovulation).
Post-Ovulation Unilateral Resistance ExerciseControl LegOne leg will undergo 2 sessions of unilateral resistance exercise during the luteal phase of the menstrual cycle (post-ovulation).
Primary Outcome Measures
NameTimeMethod
Change in Rates of Muscle Protein Synthesis6 days

The investigators will use deuterated water and skeletal muscle biopsies to calculate the synthesis of skeletal muscle proteins.

Secondary Outcome Measures
NameTimeMethod
Whole-body proteolysis6 days

The investigators will use 3-methylhistidine in urine to calculate the rate of whole-body myofibrillar protelysis

Trial Locations

Locations (1)

Exercise Metabolism Research Laboratory, McMaster Univeristy

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath